Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1.83	2.4	2.86	7.48	0.32	5.59
Short-Term Investments	12.86	8.29	9.99	0	0	0
Cash & Cash Equivalents	14.69	10.69	12.85	7.48	0.32	5.59
Cash Growth	-13.54%	-16.79%	71.77%	2210.70%	-94.21%	1.67%
Receivables	0	0	0	0	0	0.17
Other Current Assets	0.57	0.59	0.52	0.72	0.14	-0.03
Total Current Assets	15.26	11.29	13.37	8.2	0.47	5.73
Property, Plant & Equipment	0	0	0	0	0	0.72
Long-Term Investments	0	0	0	0	0	0.1
Goodwill and Intangibles	0.56	0.58	0.7	0.81	0.91	0
Other Long-Term Assets	0.3	0.3	0.38	0.35	0	0.03
Total Long-Term Assets	0.86	0.88	1.09	1.16	0.91	0.85
Total Assets	16.12	12.17	14.46	9.36	1.38	6.58
Accounts Payable	0.36	0.53	0.61	0.92	4.89	1
Current Debt	0	0	0	0	1.21	0.12
Other Current Liabilities	3.87	3.05	2.92	3.65	1.88	0
Total Current Liabilities	4.22	3.58	3.53	4.58	7.99	1.12
Long-Term Debt	0	0	0	0	0	0.21
Other Long-Term Liabilities	2.77	2.92	3.52	4.12	0	0.67
Total Long-Term Liabilities	2.77	2.92	3.52	4.12	0	0.88
Total Liabilities	7	6.51	7.05	8.7	7.99	2
Total Debt	0	0	0	0	1.21	0.33
Debt Growth	-	-	-	-	266.37%	-
Retained Earnings	-48.53	-46.2	-37.52	-28.07	-6.61	-31.13
Shareholders' Equity	9.13	5.66	7.41	0.66	-6.61	4.58
Net Cash / Debt	14.69	10.69	12.85	7.48	-0.89	5.26
Net Cash / Debt Growth	-13.54%	-16.79%	71.77%	-	-	-4.36%
Net Cash Per Share	-	-	-	0.28	-0.04	0.26
Working Capital	11.04	7.7	9.84	3.62	-7.52	4.61
Book Value Per Share	2.48	5.74	18.34	0.03	-0.33	0.23

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).